NNVC
AMEX
$1.60
NanoViricides Inc (NNVC)
NanoViricides, Inc., a nanobiopharmaceutical company, discovers, develops and markets drugs for the treatment of viral infections. The company is headquartered in Shelton, Connecticut.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $6 (+275.00%)
Market Cap
$37M
Free Cash Flow Yield
-19.80%
Beta (5Y)
1.09
Price Chart
Valuation
Market Cap$37M
P/B4.14
Profitability
EBITDA-$7.63M
EPS-$0.42
Financial Health
Free Cash Flow Yield-19.80%
Growth & Risk
EPS 5Y CAGR-12.51%
FCF 5Y CAGR-3.25%
Beta (5Y)1.09
Sharpe Ratio0.32